Search results
3 big changes coming to Medicare in 2025—and what they’ll mean for you
Fortune via Yahoo Finance· 2 days agoThe advice for people looking to enroll in Medicare Part D plans in 2025: Review your choices...
3.6 million Medicare recipients could qualify for Wegovy under new rule - UPI.com
UPI· 13 minutes agoThe U.S. Food and Drug Administration has approved the use of Wegovy (semaglutide) to reduce the...
Wegovy could soon treat millions of Medicare patients
Quartz· 4 hours agoMillions of Americans could now be eligible for Medicare to cover their prescriptions of the popular...
Millions of Medicare recipients could gain access to weight-loss drug
Newsweek· 6 hours agoMillions of overweight or obese patients with heart conditions insured under Medicare could gain...
3.6M Medicare patients could qualify for Wegovy coverage: report (NYSE:NVO)
Seeking Alpha· 4 hours agoAround 3.6M older Americans could now be eligible to have Novo Nordisk’s (NVO) weight-loss drug...
1 in 4 U.S. adults over 50 plan to never retire, study finds | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 9 hours agoWASHINGTON >> More than one-quarter of U.S. adults over age 50 say they expect to never retire and...
Wegovy Access Expands to Millions in US on Medicare, Study Finds
Bloomberg· 10 hours agoHave a confidential tip for our reporters? Medicare’s recent decision to cover Novo Nordisk A/S’s...
This Week in 340B: April 16 – April 22, 2024
The National Law Review· 4 hours agoFind this week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more ...
Analysis | Medicare stumbles managing a costly problem — chronic illness
Washington Post· 7 hours agoA few thousand doctors make at least $100,000 each in a Medicare program to manage chronic...
6 Medicare mistakes to avoid if you’re working past age 65
Bankrate via Yahoo Finance· 5 days agoThey can also answer questions about special enrollment periods, late enrollment fees and other...